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The oxidative phosphorylation (OXPHOS) system of the
mitochondrion uses the products of ∼60 nuclear genes
and 13 mitochondrial genes to generate cellular ATP.
These proteins are organized into five large com-
plexes—electron transport chain complexes I–IV and
ATP synthetase (complex V) (Hatefi 1985)—of which
complex I, or nicotinamide adenine dinucleotide
(NADH):ubiquinone oxidoreductase, is the largest.
Studies of the bovine heart have identified at least 35
complex I nuclear gene products, together with 7 mi-
tochondrially encoded proteins (Walker 1992; Skehel et
al. 1998). In the past year, our knowledge of the human
complex I genes and gene products has made substantial
progress. Here we review recent insights into these com-
ponents and their roles in health and disease.
Complex I, which is embedded in the inner mito-
chondrial membrane (IMM), serves to dehydrogenate
NADH and to shuttle electrons to coenzyme Q. This
electron transport generates a proton gradient across the
IMM, which provides the proton-motive force that is
used in ATP synthesis. The total human complex consists
of 42 subunits, 7 encoded by the mitochondrial ge-
nome and the remainder by the nuclear genome (Smei-
tink et al. 1998b). The coordinated interactions between
the nucleus and the mitochondrion that build and main-
tain this vital multiple-subunit protein complex remain
poorly understood. As of last year, however, all 35
known human nuclear-encoded cDNAs for complex I
proteins had been characterized (Loeffen et al. 1998b;
Smeitink et al. 1998b), thanks, in part, to the work of
Walker (1992), who characterized the homologous com-
plex from cattle, and also, in part, to the increasing
power of genomic methods that are readily available
through public databases. On the basis of the genetic
information available from prokaryotes and lower eu-
karyotes, we expect that knowledge about this intriguing
complex will expand rapidly in coming years. For the
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many individuals with inherited defects in complex I
function, these advances offer the prospect of efficient
diagnosis, reliable genetic counseling and prenatal di-
agnostics, better understanding of the cellular conse-
quences of complex I deficiency, and, ultimately, treat-
ment strategies more rational than those currently
available.
Nuclear Genes of Human Complex I
The exact protein composition of complex I has not
been studied in detail in mitochondria from whole hu-
man organs; however, work with bovine heart tissue has
thus far identified 35 nuclear-encoded subunits (Walker
1992; Skehel et al. 1998), including 3 flavoproteins
(FPs), 7 iron-sulfur proteins (IPs), and 24 hydrophobic
proteins (HPs) (Galante and Hatefi 1979); a recently
identified 17.2-kD subunit (Skehel et al. 1998) has not
yet been placed in any of these three groups. FP and IP
proteins from cattle, bacteria, and fungi protrude from
the IMM into the mitochondrial matrix (Grigorieff
1998; Guenebaut et al. 1998). This protruding “arm”
includes the NDUFV1 protein, which binds and transfers
electrons to NADH, as well as many proteins of the IP
group, which carry out intra- and intersubunit electron
transfer. The final electron acceptor for complex I, ubi-
quinone, is predicted to bind one or more of these pro-
teins, but no such interaction has yet been identified.
The HP fraction, embedded in the lipid bilayer of the
IMM, contains most of the nuclear-encoded proteins and
all seven mitochondrially-encoded proteins. This frac-
tion seems to mediate proton translocation from the mi-
tochondrial matrix into the intermembrane space (Be-
logrudov and Hafeti 1994).
Table 1 summarizes the present molecular data re-
garding the human nuclear-encoded complex I subunits.
Presently, the complete gene structure is known for 6 of
the 35 genes and chromosomal localization is known
for 26 of 35 (Emahazion and Brookes 1998; Emahazion
et al. 1998). A small form of complex I, consisting of
14 subunits, is found in Escherichia coli (Weidner et al.
1993). In this bacterium, all complex I genes are organ-
ized as an operon, called “Nuo” after the NADH:ubi-
quinone oxidase. In most eukaryotes, homologues of
NuoB–NuoG andNuoI are nuclear genes. Comparative
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Table 1
Human Complex I Nuclear Genes: Present Knowledge
Gene Group
and Gene
cDNA
Sequence
nDNA
Sequence
Chromosomal
Localization
Leader
Sequence Biochemical Function
Flavoprotein:
NDUFV1 (NuoF)   11q13  NADH binding, electron transfer
NDUFV2 (NuoE)   18p11.2-p11.21  Electron transfer
NDUFV3   21q22.3 
Iron-sulfur:
NDUFA5   7q31.33
NDUFS1 (NuoG)   2q33-34  Electron transfer
NDUFS2 (NuoD)   ) 
NDUFS3 (NuoC)   11p11.11 
NDUFS4   5q11.1  Phosphorylation
NDUFS5   1p34.2-p33
NDUFS6   5pter-p15.33 
Hydrophobic:
NDUFA1   Xq24-25
NDUFA2   5q31.2
NDUFA3   )
NDUFA4   )
NDUFA6   21q13.1
NDUFA7   19p13.2 Ubiquinone binding?
NDUFA8   9q33.2-34.11
NDUFA9   ) 
NDUFA10   12p 
NDUFAB1   16p12.3-12.1 Acylcarrier protein motif
NDUFB1   14q31.3
NDUFB2   7q34-35 
NDUFB3   )
NDUFB4   )
NDUFB5   ) 
NDUFB6   9p13.2
NDUFB7   19p13.12-13.11
NDUFB8   10q23.2-23.33 
NDUFB9   8p24.21
NDUFB10   16p13.3
NDUFS7 (NuoB)   19p13  Electron transfer
NDUFS8 (NuoI)   11q13.1-13.3  Electron transfer
NDUFC1   4q28-28.3
NDUFC2   )
Unknown:
17.2 kD  )
NOTE.—E. coli homologues of human complex I genes are indicated in parentheses in the first column. For primary
data, see Walker (1992), Emahazion and Brookes (1998), Emahazion et al. (1998), Loeffen et al. (1998b), Skehel
et al. (1998), Smeitink et al. (1998b), and Lin et al. (1999). Ellipses ())  unknown.
studies show that the number of nuclear-encoded com-
plex I subunits increases with the evolutionary com-
plexity of the organism. The seven human nuclear-en-
coded counterparts of the E. coli Nuo proteins, namely,
NDUFV1 and 2, NDUFS1–3, and NDUFS7 and 8,
would be predicted to carry out essential aspects of com-
plex I function, and we began our mutational analysis
of human patients with the genes for these subunits.
Nuclear-Mitochondrial Interactions
Except for complex II, in which all four known struc-
tural genes are nuclear, all components of the OXPHOS
system are under the control of both the mitochondrial
and nuclear genomes. This poses a regulatory challenge
that is unique in human cell biology. The control of
mitochondrial gene expression is relatively well known
(Shadel and Clayton 1997; Clayton 1998), but regula-
tion of the nuclear-encoded genes and coordination of
the two genomes are not. Fortunately, work in model
systems, including the fungus Neurospora crassa (Be-
logrudov and Hatefi 1994), has begun to address the
regulation of transcription and translation of these
genes, as well as intracellular signaling, complex assem-
bly, and stochiometry.
The regulatory regions of several genes encoding com-
plex I proteins have been characterized. We recently
found a consensus motif in the human NDUFV1 gene
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for binding the transcription factor nuclear respiratory
factor II (Schuelke et al. 1998). This binding sequence
motif has also been detected in other nuclear genes for
mitochondrial proteins, including those for cytochrome
c oxidase and for the b subunits of ATP-synthetase and
of the mitochondrial transcription factor. Moyes et al.
(1998) speculate that these genes respond in a modular
fashion to physiological change.
The transport of nuclear-encoded complex I gene
products to and through the IMM is poorly understood.
Transport of the complex I preproteins across the mi-
tochondrial outer membrane is presumed to occur via a
dedicated import machinery, called “Tom” for translo-
case of the outer membrane (Dekker et al. 1998). This
multiple-subunit machinery contains receptors and a
general import pore. Recently, Hill et al. (1998) showed
that Tom40, one of the eight Tom proteins, forms a
cation-selective conductance channel that binds to mi-
tochondrial-targeting sequences on the cytoplasmic face
of the mitochondrion and transports them across the
membrane. At least 15 of the known nuclear-encoded
complex I gene products, including all of the subunits
shared with the E. coli complex, contain classic mito-
chondrial-targeting leader sequences, but cis-acting tar-
geting sequences have not been defined for the remaining
proteins. Alternatively, internal targeting sequences may
be present in these proteins; Sirrenberg et al. (1998) re-
cently discovered a pathway in yeast for the mitochon-
drial transport of proteins containing internal signals.
The matrix arm and the membrane portion of com-
plex I form independently and are joined in the course
of assembly. In N. crassa, the membrane arm itself is
formed from two smaller modules, which assemble
through the action of two specific chaperones (Kuffner
et al. 1998). The functions of the components of the
OXPHOS system, particularly human and yeast cyto-
chrome c oxidase, also appear to be mediated by nuclear-
encoded factors, namely, the SURF1 protein and its yeast
homologue Shy1 (Duhig et al. 1998; Tiranti et al. 1998;
Zhu et al. 1998). No such chaperones or accessory fac-
tors are yet known for human complex I.
Complex I subunit mRNA expression appears to be
ubiquitous in human tissues, and the brain, heart, skel-
etal muscles, and kidneys accumulate these mRNAs at
high levels. Among these mRNAs, only the NDUFB6
message is expressed most strongly in the kidney (Smei-
tink et al. 1998a), suggesting that mutations inNDUFB6
may cause distinctive phenotypes. So far, no mutations
in NDUFB6 have been found in people with isolated
complex I deficiency.
Isolated Human Complex I Deficiency
Mitochondriocytopathies occur with an estimated in-
cidence of 1 per 10,000 live births, and isolated complex
I deficiency is one of those most frequently encountered
(Robinson 1998). The first clinical symptoms of complex
I deficiency, presenting either at birth or in early child-
hood, seem to result from brain dysfunction, sometimes
combined with defects in other energy-consuming or-
gans, such as the skeletal muscle and the heart. For this
reason, complex I deficiencies are grouped among the
mitochondrial encephalomyopathies. Robinson (1998)
categorized complex I–deficient patients into threemajor
clinical groups. The most common presentation is Leigh
syndrome (Leigh 1951), with cardiomyopathy occurring
in ∼40% of Leigh syndrome patients (Morris et al. 1996;
Rahman et al. 1996). A second category often seen is
fatal neonatal lactic acidosis. A relatively uncommon
third group comprises patients who present with he-
patopathy and tubulopathy with very mild symptoms,
such as exercise intolerance, or with cardiomyopathy
and cataracts. In our experience, the majority of patients
with complex I deficiency die before the age of 5 years
of a multisystem disorder, usually Leigh syndrome or a
Leigh-like syndrome. In contrast to the patients de-
scribed by Robinson (1998), none of our patients with
cardiomyopathy or cataract showed isolated complex I
deficiency (Sengers et al. 1975; Smeitink et al. 1989).
Furthermore, none of the 40 patients with whom we
have worked who exhibited isolated complex I defi-
ciency in their cultured fibroblasts or myocytes appear
to fit into Robinson’s third category (J. L. C.M. Loeffen,
J. A. M. Smeitink, J. M. Trijbels, A. J. Janssen, R. T. P.
Triepels, R. C. A. Sengers, and L. P. van den Heuvel,
unpublished data).
Since the elucidation of the complete human mito-
chondrial genome, mutational analysis of mtDNA has
attracted much attention as a way to explore the un-
derlying cause of isolated complex I deficiency. The most
frequently observed pathological mtDNA mutations are
found in the genes for mitochondrial tRNAs for leucine
(T3271C, A3243G) and lysine (A8344G, T8356C) and
in the protein-encoding subunits ND1 (T4160A,
G3460A), ND4 (G11778A), and ND6 (T14484C,
G14459A) (Wallace 1992; Zeviani et al. 1998). Since
the underlying genetic defect can be ascribed to muta-
tions in mtDNA in only ∼5% of complex I–deficient
patients (Liang and Wong 1998), we focused our atten-
tion on mutational analysis of nuclear complex I genes
and selected a group of 20 patients with isolated com-
plex I deficiency in whom the enzyme deficiency was
confirmed in more than one tissue. Since maternal in-
heritance was not evident in this group, the known mi-
tochondrial DNA mutations associated with complex I
deficiency could be excluded. We started our search for
mutations in subunits highly conserved during evolution.
Mutational analysis of eight nuclear genes encoding pro-
teins of complex I revealed mutations in five of our pa-
tients and two additional siblings (Loeffen et al. 1998a;
van den Heuvel et al. 1998; Schuelke et al. 1999; Triepels
Table 2
Nuclear Gene Mutations in Patients with Isolated Complex I Deficiency
AFFECTED GENE
(MUTATION[S])
SEX/AGE
(MO)a SYMPTOMS AT PRESENTATION COURSE OF ILLNESS
LACTIC ACID CONCENTRATION
MRI FINDINGSc
AGE AT DEATH/
POSTMORTEM FINDINGSdBlood Urine CSFb
NDUFS4 (5-bp
duplication)
M/8 Vomiting, failure to thrive,
hypotonia
Progressive Normal Normal Normal Atrophy, basal ganglia
abnormalities
16 mo
NDUFS8 (P79L,
R102H)
M/!1 Feeding difficulties, hypotonia,
episodic apnea and cyanosis
Progressive, moderate
hypertrophic cardiopathy
Increased Increased Increased Atrophy, symmetrical
hypodensities
11 weeks (LS confirmed)
NDUFS7 (V122M) M/26 Feeding problems, dysarthria,
ataxia
Progressive Normal Normal Sl. incr. Symmetrical hypodensities 3.5 years (LS confirmed)
NDUFS7 (V122M) M/11 Vomiting Progressive after infection
(3.4 years)
Normal Normal Normal Symmetrical hypodensities 5 years (LS confirmed)
NDUFV1 (R59X,
T423M)
M/5 Vomiting, strabismus, hypotonia Progressive, myoclonic
epilepsy
Increased Normal Increased Atrophy 14 mo
NDUFV1 (R59X,
T423M)
M/7 Vomiting, strabismus, hypotonia Progressive, myoclonic
epilepsy
Increased Normal Increased Atrophy 17 mo
NDUFV1 (A341V) F/6 Infantile myoclonic epilepsy Progressive Normal Normal Increased Atrophy, progressive macro-
cystic leucodystrophy
Alive at age 10 years
a Age at presentation.
b CSF  cerebrospinal fluid; Sl. incr.  slightly increased.
c MRI  magnetic resonance imaging.
d LS  Leigh syndrome.
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et al., in press). Interestingly, none of our subjects carry
mutations in any of the 18 complex I subunit genes we
have studied that are not conserved with E. coli. We are
continuing to search formutations in the remaining com-
plex I structural genes in this group of patients. On the
basis of precedent from N. crassa (Kuffner et al. 1998),
it is possible that some of these individuals will carry
mutations in genes that are required for the folding or
assembly of complex I proteins.
The currently known mutations and clinical features
of our complex I–deficient patients are summarized in
table 2. Six patients had a progressive and ultimately
fatal multisystemic disorder in which cerebral dysfunc-
tion was the most prominent clinical sign; one is alive
at 10 years of age but is severely handicapped. Increased
lactic acid concentration, considered to be one of the
hallmarks of a mitochondriocytopathy, was certainly not
present in all body fluids routinely investigated. Strik-
ingly, one patient showed no lactic acid elevation, not
even after a series of provocative tests. We assume, on
the basis of past experience with mtDNA studies, that
the inheritance pattern of most children with enzymatic
complex I deficiency is autosomal recessive.
Outstanding Questions
The cloning of the nuclear genes and cDNAs that en-
code the human complex I components should make
prenatal and postnatal diagnosis of complex I deficiency
possible, although the large number of nuclear and mi-
tochondrial genes involved is still somewhat daunting.
Chip technology will certainly increase our diagnostic
abilities in the near future. At present, extensive muta-
tional detection studies of nuclear genes are performed
only after the common mtDNA mutations have been
excluded.
Before the emerging molecular data can be put to use
to benefit families with complex I deficiency, we badly
need answers to several fundamental questions. First,
until detailed protein studies of the complex have been
performed with human cells, the total number of the
human complex I nuclear genes will remain uncertain.
Quite recently, Walker’s group, which had just reported
the identity of the 42d complex I subunit (Skehel et al.
1998), announced the presence of a 43d subunit in bo-
vine heart. Furthermore, the stochiometry of this mul-
tiprotein subunit complex has not been explored in hu-
mans, nor have any studies addressed possible
differences between cell types in the composition of the
complex, which could account for variable clinical pre-
sentation of this mitochondrial encephalomyopathy. In
addition, very limited information is available about the
expression, intracellular transport, and assembly of the
subunits of the complex, all steps that might be impaired
in individuals deficient in OXPHOS. Insights into these
medically relevant biosynthesis issues may come from
detailed studies of bacteria and fungi, as was seen re-
cently with the identification of the SURF1 gene in cy-
tochrome c oxidase–deficient patients with Leigh syn-
drome (Tiranti et al. 1998; Zhu et al. 1998). Finally, the
metabolic and general physiological effects of aberrant
complex I function will need to be explored if rational
therapeutic strategies are to be developed.
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